Industry News for Business Leaders
AutomationChemical & BiotechFeaturedMedical Industry

Automation’s Role in Accelerating Large-Scale Synthetic Human Tissue Production

Automation’s Role in Accelerating Large-Scale Synthetic Human Tissue Production
DirectIndustry had the opportunity to visit ARMI, the Advanced Regenerative Manufacturing Institute (PHOTO. C. RUSTICI)

In the United States, there is an ambition to create a regenerative medicine industry on the East Coast. Leveraging the expertise of major players like Rockwell Automation, the goal is to establish an innovative ecosystem. Recently, DirectIndustry visited ARMI, the Advanced Regenerative Manufacturing Institute just an hour north of Boston.

ARMI, or the Advanced Regenerative Manufacturing Institute, has a twofold mission: to streamline the production of human tissue for organs and to automate and democratize the industrial process, allowing for the installation of desktop units in clinics and medical offices. The challenge is to scale up the manufacturing of human cells cost-effectively.

ARMI’s prototype tissue foundry, part of the BioFabUSA project, features an automated production line for cell manufacturing, aiming to achieve GMP readiness. The ultimate goal is to enable mass production of tissues and organs, addressing the challenge of variability in human cells and advancing personalized transplantation with minimized rejection risks.

READ MORE

Advertisement
Advertisement
Advertisement
Advertisement
Advertisement